Literature DB >> 8743460

Mechanisms of fluid secretion by polycystic epithelia.

L P Sullivan1, J J Grantham.   

Abstract

We have sought to determine the mechanisms driving fluid secretion by the cystic epithelium in autosomal dominant polycystic kidney disease (ADPKD). We have performed in vitro experiments on intact cysts dissected from discarded ADPKD kidneys, on monolayers of cells cultured from the cystic epithelium and on microcysts clonally derived from single cultured cells. These preparations absorb fluid in the control state but secrete fluid in response to native cyst fluid, to adenylate cyclase agonists and to permeant analogues of cAMP. Measurements of short-circuit current and transepithelial voltage in the monolayers indicate that anion secretion must drive the fluid secretion. Fluid secretion by the intact cysts was inhibited by basolateral application of ouabain but not by apical application. The effect of ouabain on fluid secretion and short-circuit current in the monolayers followed the same pattern. Thus the functional Na,K-ATPase enzyme complex is located only in the basolateral membrane of the cystic cells and serves to maintain the transmembrane chemical and electrical gradients that drive anion secretion by other transport mechanisms. Fluid secretion and short-circuit current in the cultured monolayers was inhibited by the basolateral application of the Na-K-2Cl cotransporter inhibitors, bumetanide and furosemide, and by apical application of the chloride channel blocker, diphenylamine-2-carboxylate (DPC). These data suggest that chloride is the anion that is actively secreted. Preliminary experiments utilizing the monolayers and the microcysts and measuring cell chloride concentration and chloride efflux across the apical membrane support this conclusion. Other preliminary data indicate that the cystic fibrosis transmembrane conductance regulator is present in the apical membrane. Thus active chloride transport generates fluid secretion by the cystic epithelium.

Entities:  

Mesh:

Year:  1996        PMID: 8743460     DOI: 10.1038/ki.1996.230

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

Review 1.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

2.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

3.  Pkd1 is required for male reproductive tract development.

Authors:  Xuguang Nie; Lois J Arend
Journal:  Mech Dev       Date:  2013-08-09       Impact factor: 1.882

Review 4.  Recent advances in understanding ion transport mechanisms in polycystic kidney disease.

Authors:  Anastasia V Sudarikova; Valeriia Y Vasileva; Regina F Sultanova; Daria V Ilatovskaya
Journal:  Clin Sci (Lond)       Date:  2021-11-12       Impact factor: 6.124

5.  Dopamine receptor antagonists as potential therapeutic agents for ADPKD.

Authors:  Parama Paul; Sreekumar Ramachandran; Sheng Xia; Jay R Unruh; Juliana Conkright-Fincham; Rong Li
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.